Literature DB >> 28215124

The ATHOS-3 trial, angiotensin II and The Three Musketeers.

Rinaldo Bellomo1, Andrew Hilton2.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28215124

Source DB:  PubMed          Journal:  Crit Care Resusc        ISSN： 1441-2772            Impact factor:   2.159


× No keyword cloud information.
  2 in total

1.  Treatment with angiotensin II in COVID-19 patients may not be beneficial.

Authors:  Susanne Rysz; Francesca Campoccia Jalde; Anders Oldner; Lars I Eriksson; Johan Lundberg; Malin Jonsson Fagerlund
Journal:  Crit Care       Date:  2020-09-04       Impact factor: 9.097

Review 2.  Angiotensin in Critical Care.

Authors:  Anna Hall; Laurence W Busse; Marlies Ostermann
Journal:  Crit Care       Date:  2018-03-20       Impact factor: 9.097
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.